GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $267,020 | +113.1% | 3,921 | 0.0% | 0.01% | +160.0% |
| Q2 2022 | $125,276 | -7.8% | 3,921 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $135,823 | -72.1% | 3,921 | -76.4% | 0.01% | -28.6% |
| Q4 2021 | $486,409 | +14.9% | 16,618 | 0.0% | 0.01% | +16.7% |
| Q3 2021 | $423,427 | -27.2% | 16,618 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $581,962 | +231.1% | 16,618 | +285.3% | 0.01% | +166.7% |
| Q1 2021 | $175,755 | -10.0% | 4,313 | -4.3% | 0.00% | 0.0% |
| Q4 2020 | $195,241 | -21.9% | 4,508 | -0.5% | 0.00% | -25.0% |
| Q3 2020 | $249,894 | -14.9% | 4,532 | -2.5% | 0.00% | -20.0% |
| Q2 2020 | $293,491 | -67.4% | 4,649 | -73.6% | 0.01% | -73.7% |
| Q1 2020 | $901,177 | -34.9% | 17,639 | +1.2% | 0.02% | -17.4% |
| Q4 2019 | $1,385,034 | +58.9% | 17,424 | -3.0% | 0.02% | +53.3% |
| Q3 2019 | $871,565 | -3.4% | 17,963 | +4.7% | 0.02% | 0.0% |
| Q2 2019 | $902,405 | +1.0% | 17,156 | +1.7% | 0.02% | -6.2% |
| Q1 2019 | $893,088 | +33.4% | 16,873 | +3.4% | 0.02% | +23.1% |
| Q4 2018 | $669,567 | +8.0% | 16,311 | 0.0% | 0.01% | +18.2% |
| Q3 2018 | $619,818 | -99.9% | 16,311 | 0.0% | 0.01% | -8.3% |
| Q2 2018 | $737,257,000 | +24.3% | 16,311 | +32.8% | 0.01% | +50.0% |
| Q1 2018 | $593,172,000 | +124778.3% | 12,281 | +1.8% | 0.01% | +33.3% |
| Q4 2017 | $475,000 | -40.0% | 12,066 | -52.7% | 0.01% | +20.0% |
| Q3 2017 | $792,000 | +13.6% | 25,492 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $697,000 | +64.0% | 25,492 | +121.0% | 0.01% | +66.7% |
| Q1 2017 | $425,000 | +154.5% | 11,535 | 0.0% | 0.00% | +200.0% |
| Q4 2016 | $167,000 | -37.2% | 11,535 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $266,000 | +39.3% | 11,535 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $191,000 | -17.3% | 11,535 | +61.1% | 0.00% | -50.0% |
| Q4 2015 | $231,000 | – | 7,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |